ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ


https://doi.org/10.23934/2223-9022-2017-6-2-112-113

Полный текст:


Аннотация

Изучение острого коронарного синдрома (ОКС) у больных хронической болезнью почек (ХБП) является одним из направлений современной кардиологии. Распространенность, течение, прогноз и тактика лечения инфаркта миокарда при ХБП недостаточно изучены. Анализ литературных источников позволяет констатировать: ХБП при ОКС удваивает риск смерти (РС) и неблагоприятных сердечно-сосудистых событий в ближайшем и отдаленном периодах; определение стадии ХБП необходимо с целью прогнозирования госпитальной и отдаленной смертности инфарктных больных; диагностика ОКС на поздних стадиях ХБП сложна; ХБП следует считать независимым РС после проведения чрескожных коронарных вмешательств и коронарного шунтирования.

Об авторах

Х. Г. Алиджанова
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»
Россия

доктор медицинских наук, старший научный сотрудник отделения неотложной клинической кардиологии с методами неинвазивной функциональной диагностики,

Москва



О. Н. Ржевская
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»
Россия
Москва


М. А. Сагиров
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»
Россия
Москва


Г. А. Газарян
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского Департамента здравоохранения г. Москвы»
Россия
Москва


Список литературы

1. Моисеев B.C., Мухин Н.А., Смирнов А.В. и др. Сердечно-сосудистый риск и хроническая болезнь почек: стратегии кардио- и нефропротекции. Российский кардиологический журнал. 2014; 8(112): 7–37.

2. Himmelfarb J. Chronic kidney disease and the public health: gaps in evidence from interventional trials. JAMA. 2007; 29(23): 2630–2633. DOI: 10.1001/jama.297.23.2630.

3. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J. Am. Soc. Nephrol. 2004; 15(5): 1307–1315. PMID: 15100371.

4. Briasoulis A., Bakris G.L. Chronic kidney disease as a coronary artery disease risk equivalent. Curr. Cardiol. Rep.2013; 15(3): 340. DOI: 10.1007/s11886-012-0340-4.

5. Wright R.S., Reeder G.S., Herzog C.A., et al. Acute myocardial infarction and renal dysfunction: a high-risk combination. Ann. Intern. Med. 2002; 137(7): 563–570. DOI: 10.7326/0003-4819-137-7-200210010-00007.

6. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National kidney foundation task force on cardiovascular disease. Am. J. Kidney Dis. 1998; 32(5): 853–906. DOI: 10.1016/S0272-6386(98)70145-3.

7. Herzog C.A., Li S., Weinhandl E.D., et al. Survival of dialysis patients after cardiac arrest and the impact of implantable cardioverter defibrillators. Kidney Int. 2005; 68(2): 818–825. DOI: 10.1111/j.1523-1755.2005.00462.x.

8. Franczyk-Skóra B., Gluba A., Olszewski R., et al. Heart function disturbances in chronic kidney disease – echocardiographic indices. Arch. Med. Sci. 2014; 10(6): 1109–1116. DOI: 10.5114/aoms.2014.47822.

9. Kilickesmez K.O., Abaci O., Okcun B., et al. Chronic kidney disease as a predictor of coronary lesion morphology. Angiology. 2010; 61(4): 344–349. DOI: 10.1177/0003319709351875.

10. Sabe M.A., Claggett B., Burdmann E.A., et al. Coronary Artery Disease Is a Predictor of Progression to Dialysis in Patients With Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Anemia: An Analysis of the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). J. Am. Heart Assoc. 2016; 5(4): e002850. DOI: 10.1161/JAHA.115.002850.

11. Balla S., Nusair M.B., Alpert M.A. Risk factors for atherosclerosis in patients with chronic kidney disease: recognition and management. Curr Opin. Pharmacol. 2013; 13(2): 192–199. DOI: 10.1016/j.coph.2012.12.001.

12. Olechnowicz-Tietz S., Gluba A., Paradowska A., et al. The risk of atherosclerosis in patients with chronic kidney disease. Int. Urol. Nephrol. 2013; 45(6): 1605–1612. DOI: 10.1007/s11255-013-0407-1.

13. Schlieper G., Schurgers L., Brandenburg V., et al. Vascular calcification in chronic kidney disease: an update. Nephrol. Dial. Transplant. 2016; 31(1): 31–39. DOI: 10.1093/ndt/gfv111.

14. Gupta J., Mitra N., Kanetsky P.A., et al. Association between albuminuria, kidney function, and inflammatory biomarker profile. Clin. J. Am. Soc. Nephrol. 2012; 7(12): 1938–1946. DOI: 10.2215/CJN.03500412.

15. Gupta J., Dominic E.A., Fink J.C., et al. Association between inflammation and cardiac geometry in chronic kidney disease: findings from the CRIC Study. PLoS ONE. 2015; 10(4): e0124772. DOI: 10.1371/journal.pone.0124772.

16. Kato K., Yonetsu T., Jia H., et al. Non–culprit coronary plaque characteristics of chronic kidney disease. Circ. Cardiovasc. Imaging. 2013; 6(3): 448–456. DOI: 10.1161/CIRCIMAGING.112.000165.

17. Madhavan M.V., Tarigopula M., Mintz G.S., et al. Coronary artery calcification: pathogenesis and prognostic implications. J. Am. Coll. Cardiol. 2014; 63(17): 1703–1714. DOI: 10.1016/j.jacc.2014.01.017.

18. Goodman W.G., London G., Amann K., et al. Vascular calcification in chronic kidney disease. Am. J. Kidney Dis. 2004; 43(3): 572–579. PMID: 14981617.

19. Kiu Weber C.I., Duchateau-Nguyen G., Solier C., et al. Cardiovascular risk markers associated with arterial calcification in patients with chronic kidney disease Stages 3 and 4. Clin. Kidney J. 2014; 7(2): 167–173. DOI: 10.1093/ckj/sfu017.

20. Kawai H., Sarai M., Motoyama S., et al. Coronary plaque characteristics in patients with mild chronic kidney disease. Analysis by 320-row area detector computed tomography. Circ. J. 2012; 76(6): 1436–1441. PMID: 22453001.

21. Ohtake T., Kobayashi S., Moriya H., et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J. Am. Soc. Nephrol. 2005; 16(4): 1141–1148. DOI: 10.1681/ASN.2004090765.

22. Nakano T., Ninomiya T., Sumiyoshi S., et al. Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: the Hisayama study. Am. J. Kidney Dis. 2010; 55(1): 21–30. DOI: 10.1053/j.ajkd.2009.06.034.

23. Charytan D.M., Shelbert H.R., Di Carli M.F. Coronary microvascular function in early chronic kidney disease. Circ. Cardiovasc. Imaging. 2010; 3(6): 663–671. DOI: 10.1161/CIRCIMAGING.110.957761.

24. Matsushita K., Coresh J., Sang Y., et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2015; 3(7): 514–525. DOI: 10.1016/S2213-8587(15)00040-6.

25. Tonelli M., Muntner P., Lloyd A., et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012; 380(9844): 807–814. DOI: 10.1016/S0140-6736(12)60572-8.

26. McCullough P.A., Jurkovitz C.T., Pergola P.E., et al. Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch. Intern. Med. 2007; 67(11): 1122–1129. DOI: 10.1001/archinte.167.11.1122.

27. Hui X., Matsushita K., Sang Y., et al. CKD and cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study: interactions with age, sex, and race. Am. J. Kidney Dis. 2013; 62(4): 691–702. DOI: 10.1053/j.ajkd.2013.04.010.

28. Masoudi F.A., Plomondon M.E., Magid D.J., et al. Renal insufficiency and mortality from acute coronary syndromes. Am. Heart J. 2004; 147(4): 623–629. DOI: 10.1016/j.ahj.2003.12.010.

29. Smith G.L., Masoudi F.A., Shlipak M.G., et al. Renal Impairment Predicts Long-Term Mortality Risk after Acute Myocardial Infarction. J. Am. Soc. Nephrol. 2008; 19(1): 141–150. DOI: 10.1681/ASN.2007050554.

30. Rozenbaum Z., Leader A., Neuman Y., et al. Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Acute Coronary Syndrome. Am. J. Med. 2016; 129(2): 187–194. DOI: 10.1016/j.amjmed.2015.08.017.

31. Ozaki T., Yamada T., Morita T., et al. The ratio of contrast media volume to the estimated glomerular filtration rate and syntax score predict 3-year poor outcome in patients with acute coronary syndrome and chronic kidney disease undergoing emergency coronary procedure. J. Am. Coll. Cardiol. 2016; 67(13 Suppl): S70.

32. Pun P.H., Al-Khatib S.M., Han J.Y., et al. Implantable cardioverterdefibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials. Am. J. Kidney Dis. 2014; 64(1): 32–39. DOI: 10.1053/j.ajkd.2013.12.009.

33. Inrig J.K., Patel U.D., Briley L.P., et al. Mortality, kidney disease and cardiac procedures following acute coronary syndrome. Nephrol. Dial. Transplant. 2008; 23(3): 934–940. DOI: 10.1093/ndt/gfm689.

34. Fox C.S., Muntner P., Chen A.Y., et al. Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network Registry. Circulation. 2010; 121(3): 357–365. DOI: 10.1161/CIRCULATIONAHA.109.865352.

35. Lee S.H., Kim YJ, Kim W., et al. Clinical outcomes and therapeutic strategy in patients with acute myocardial infarction according to renal function: data from the Korean Acute Myocardial Infarction Registry. Circ. J. 2008; 72(9): 1410–1418. PMID: 18724014.

36. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation. 2002; 106(8): 974–980. PMID: 12186803.

37. Cardarelli F., Bellasi A., Ou F.S., et al. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am. J. Cardiol. 2009; 103(6): 766–771. DOI: 10.1016/j.amjcard.2008.11.033.

38. Saad M., Karam B., Faddoul G., et al. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III-V, and ESRD. Int. J. Nephrol. Renovasc. Dis. 2016; 9: 5–10. DOI: 10.2147/IJNRD.S91567.

39. Seifert M.E., de Las Fuentes L., Ginsberg C., et al. Left ventricular mass progression despite stable blood pressure and kidney function in stage 3 chronic kidney disease. Am. J. Nephrol. 2014; 39(5): 392–399. DOI: 10.1159/000362251.

40. Collins A.J., Foley R., Herzog C., et al. Excerpts from the United States Renal Data System 2007 annual data report. Am. J. Kidney Dis. 2008; 51(1 Suppl 1): S1–S320. DOI: 10.1053/j.ajkd.2007.11.001.

41. Sittichanbuncha Y., Sricharoen P., Tangkulpanich P., Sawanyawisuth K. The appropriate troponin T level associated with coronary occlusions in chronic kidney disease patients. Ther. Clin. Risk. Manag. 2015; 11: 1143–1147. DOI: 10.2147/TCRM.S85671.

42. Twerenbold R., Wildi K., Jaeger C., et al. Optimal Cutoff Levels of More Sensitive Cardiac Troponin Assays for the Early Diagnosis of Myocardial Infarction in Patients With Renal Dysfunction. Circulation. 2015; 131(23): 2041–2050. DOI: 10.1161/CIRCULATIONAHA.114.014245.

43. Bangalore S., Guo Y., Samadashvili Z., et al. Revascularization in Patients with Multivessel Coronary Artery Disease and Chronic Kidney Disease Everolimus Eluting Stents vs. Coronary Artery Bypass Graft Surgery. J. Am. Coll. Cardiol. 2015; 66(11): 1209–1220. DOI: 10.1016/j.jacc.2015.06.1334.

44. Szummer K., Lundman P., Jacobson S.H., et al. Influence of renal function on the effects of early revascularization in non-ST-elevation myocardial infarction: data from the Swedish Web-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART). Circulation. 2009; 120(10): 851–858. DOI: 10.1161/CIRCULATIONAHA.108.838169.

45. Baber U., Mehran R. Coronary Artery Revascularization in Chronic Kidney Disease Time for a Randomized Trial. Circ. Cardiovasc. Interv. 2015; 8(1): e002140. DOI: 10.1161/CIRCINTERVENTIONS.114.002140.

46. James M.T., Pannu N. Early-invasive strategies for the management of coronary heart disease in chronic kidney disease: is acute kidney injury a consideration? Curr. Opin. Nephrol. Hypert. 2014; 23(3): 283–290. DOI: 10.1097/01.mnh.0000444819.03121.4b.

47. Shroff G.R., Solid C.A., Herzog C.A. Long-term survival and repeat coronary revascularization in dialysis patients after surgical and percutaneous coronary revascularization with drug-eluting and bare metal stents in the United States. Circulation. 2013; 127(18): 1861–1869. DOI: 10.1161/CIRCULATIONAHA.112.001264.

48. Ertelt K., Généreux P., Mintz G.S., et al. Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial). Am. J. Cardiol. 2013; 112(11): 1730–1737. DOI: 10.1016/j.amjcard.2013.07.038.

49. Castagna M.T., Mintz G.S., Ohlmann P., et al. Incidence, location, magnitude, and clinical correlates of saphenous vein graft calcification: an intravascular ultrasound and angiographic study. Circulation. 2005; 111(9): 1148–1152. DOI: 10.1161/01.CIR.0000157160.69812.55.

50. Roberts J.K., McCullough P.A. The management of acute coronary syndromes in patients with chronic kidney disease. Adv. Chronic. Kidney Dis. 2014; 21(6): 472–479. DOI: 10.1053/j.ackd.2014.08.005.

51. Rhee J.W., Wiviott S.D., Scirica B.M., et al. Clinical features, use of evidence-based therapies, and cardiovascular outcomes among patients with chronic kidney disease following non-ST-elevation acute coronary syndrome. Clin. Cardiol. 2014; 37(6): 350–356. DOI: 10.1002/clc.22253.

52. Palmer S.C., Di Micco L., Razavian M. et al. Antiplatelet agents for chronic kidney disease. Cochrane Database Syst Rev. 2013; 2: CD008834. DOI: 10.1002/14651858.CD008834.pub2.

53. Nauta S.T., van Domburg R.T., Nuis R.J., et al. Decline in 20-year mortality after myocardial infarction in patients with chronic kidney disease: evolution from the prethrombolysis to the percutaneous coronary intervention era. Kidney Int. 2013; 84(2): 353–358. DOI: 10.1038/ki.2013.71.

54. Kurtul A., Murat S.N., Yarlioglues M., et al. Mild to Moderate Renal Impairment Is Associated With No-Reflow Phenomenon After Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction. Angiology. 2015; 66(7): 644–651. DOI: 10.1177/0003319714546738.

55. Tsai T.T., Messenger J.C., Brennan M.J., et al. Safety and efficacy of drugeluting stents in older patients with chronic kidney disease: a report from the linked CathPCI Registry-CMS claims database. J. Am. Coll. Cardiol. 2011; 58(18): 1859–1869. DOI: 10.1016/j.jacc.2011.06.056.

56. Chan W., Ivanov J., Ko D., et al. Clinical Outcomes of Treatment by Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graft Surgery in Patients With Chronic Kidney Disease Undergoing Index Revascularization in Ontario. Circ. Cardiovasc. Interv. 2015; 8(1): e001973. DOI: 10.1161/CIRCINTERVENTIONS.114.001973.

57. Windecker S., Kolh P., Alfonso F., et al. 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention. 2015; 10(9): 1024–1094. DOI: 10.4244/EIJY14M09_01.

58. Bangalore S., Vlachos H.A., Selzer F., et al. Percutaneous coronary intervention of moderate to severe calcified coronary lesions: insights from the National Heart, Lung, and Blood Institute Dynamic Registry. Catheter Cardiovasc. Interv. 2011; 77(1): 22–28. DOI: 10.1002/ccd.22613.

59. Iakovou I., Schmidt T., Bonizzoni E., et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drugeluting stents. JAMA. 2005; 293(17): 2126–2130. DOI: 10.1001/jama.293.17.2126.


Дополнительные файлы

Для цитирования: Алиджанова Х.Г., Ржевская О.Н., Сагиров М.А., Газарян Г.А. ПРОГНОСТИЧЕСКОЕ ЗНАЧЕНИЕ ХРОНИЧЕСКОЙ БОЛЕЗНИ ПОЧЕК У БОЛЬНЫХ С ОСТРЫМ КОРОНАРНЫМ СИНДРОМОМ. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2017;6(2):132-139. https://doi.org/10.23934/2223-9022-2017-6-2-112-113

For citation: Alidzhanova K.G., Rzhevskaya O.N., Sagirov M.A., Gazaryan G.A. PROGNOSTIC IMPORTANCE OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH ACUTE CORONARY SYNDROME. Russian Sklifosovsky Journal "Emergency Medical Care". 2017;6(2):132-139. (In Russ.) https://doi.org/10.23934/2223-9022-2017-6-2-112-113

Просмотров: 163

Обратные ссылки

  • Обратные ссылки не определены.


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 2223-9022 (Print)
ISSN 2541-8017 (Online)